Ensign Group (ENSG) just posted Q1 2026 results with revenue of US$1.4 billion, basic EPS of US$1.73 and net income of US$99.7 million, setting the tone for the new fiscal year. Over the past five quarters, revenue has moved from US$1.17 billion in Q1 2025 to US$1.39 billion in Q1 2026, while quarterly basic EPS has increased from US$1.41 to US$1.73, with trailing twelve month net income at US$363.4 million. With net profit margins over the last year near 7%, the focus now is on how consistently the company can convert this revenue base into earnings that support its long term growth profile.

See our full analysis for Ensign Group.

With the latest numbers on the table, the next step is to see how these results line up with the widely held narratives around Ensign Group's growth, risks and profitability.

TTM earnings growth of 17.4% alongside 6.9% net margin

• Over the last twelve months, Ensign Group generated US$5.3b in revenue and US$363.4 million in net income, with earnings up 17.4% and a net profit margin of 6.9% compared with 7.0% a year earlier.
• Supporters of a more bullish view point to this combination of revenue scale and earnings growth, yet the slight margin slip keeps the story balanced rather than one sided.
  • The trailing twelve month EPS of US$6.32 sits above the earlier US$5.44 level from Q1 2025. This heavily supports the idea of a business that has been growing its per share profitability over time.
  • At the same time, the 6.9% net margin versus 7.0% a year earlier shows that profitability is not expanding across every metric, which tempers the strongest bullish claims about efficiency gains.

To see how investors are turning these numbers into a bigger story around growth, risks, and valuation, check out how the community is framing Ensign Group's long term narrative in one place with the Curious how numbers become stories that shape markets? Explore Community Narratives.

Five quarter run of higher quarterly EPS

• Quarterly basic EPS has moved from US$1.40 in Q1 2025 to US$1.73 in Q1 2026, with each reported quarter in between (US$1.48, US$1.46, US$1.66) sitting below the latest print yet above the starting point.
• Bulls often focus on this kind of EPS trend as evidence of a resilient earnings engine, but the data also highlight a few checks for that view.
  • Across the same five quarter stretch, quarterly net income has ranged from US$79.7 million to US$99.7 million, which supports the bullish idea that profit dollars are building, not just EPS boosted by other factors.
  • However, with margins at 6.9% for the trailing twelve months versus 7.0% previously, the bullish angle that profitability quality is improving across the board is not fully backed by the margin data.

Premium valuation versus 29.5x P/E and DCF fair value

• The shares trade on a trailing P/E of 29.5x compared with 15.3x for peers and 24.9x for the broader US Healthcare industry, while the current price of US$183.72 sits above a DCF fair value estimate of US$143.13.
• Critics who take a more bearish angle argue that this premium matters, and the supplied numbers give them several points to lean on.
  • The gap between 29.5x P/E and a 15.3x peer average illustrates that investors are paying almost double the peer multiple. This fits a bearish concern that the stock carries rich expectations relative to similar companies.
  • The US$183.72 share price compared with the US$143.13 DCF fair value estimate further supports the argument that expectations embedded in the price are ahead of the modeled cash flow profile, even with earnings having grown 17.4% over the past year.

Next Steps

Don't just look at this quarter; the real story is in the long-term trend. We've done an in-depth analysis on Ensign Group's growth and its valuation to see if today's price is a bargain. Add the company to your watchlist or portfolio now so you don't miss the next big move.

The mix of earnings growth and a premium P/E has supporters and skeptics, so it is worth weighing the full picture for yourself. If you want a quick way to see what the market is currently optimistic about, start with the 2 key rewards.

See What Else Is Out There

Ensign Group combines rising earnings with a 29.5x P/E, slightly softer margins and a share price above a DCF fair value estimate, which raises valuation questions.

If you are uneasy about paying up when growth and margins are not clearly accelerating, let the 51 high quality undervalued stocks guide you toward ideas where price and fundamentals look more closely aligned.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.